Testimony on Liprotamase
Testimony to the FDA Gastrointestinal Drug Advisory Committee
RegardingLiprotamase – Risk : Benefit Assessment Ethics of Further Clinical Trials
Michael Carome, M.D.
Sidney Wolfe, M.D.
Testimony to the FDA Gastrointestinal Drug Advisory Committee
RegardingLiprotamase – Risk : Benefit Assessment Ethics of Further Clinical Trials
Michael Carome, M.D.
Sidney Wolfe, M.D.